KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) EPS (Weighted Average and Diluted) (2016 - 2026)

Insulet filings provide 10 years of EPS (Weighted Average and Diluted) readings, the most recent being $1.43 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 3.62% to $1.43 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.49, a 39.62% decrease, with the full-year FY2025 number at $3.48, down 39.79% from a year prior.
  • EPS (Weighted Average and Diluted) hit $1.43 in Q4 2025 for Insulet, up from $1.24 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.59 in Q2 2024 to a low of -$0.5 in Q2 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.42 (2021), compared with a mean of $0.66.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 268.18% in 2021 and later surged 1025.0% in 2023.
  • Insulet's EPS (Weighted Average and Diluted) stood at $0.42 in 2021, then crashed by 40.48% to $0.25 in 2022, then surged by 488.0% to $1.47 in 2023, then dropped by 6.12% to $1.38 in 2024, then increased by 3.62% to $1.43 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $1.43 (Q4 2025), $1.24 (Q3 2025), and $0.32 (Q2 2025) per Business Quant data.